580
Views
3
CrossRef citations to date
0
Altmetric
Letter to the Editors

Use of sirolimus in a case of severe paraquat poisoning

, , , &
Pages 778-779 | Received 08 Feb 2007, Accepted 01 Jul 2007, Published online: 20 Oct 2008

References

  • EA Lock, and MF Wilks. ParaquatHandbook of pesticide toxicology 2ndRI Krieger. Academic Press, San Diego, CA, (2001), 1559–1592.
  • M Eddleston, MF Wilks, and NA Buckley. (2003). Prospects for treatment of paraquat-induced lung fibrosis with immunosuppressive drugs and the need for better prediction of outcome: a systematic review. Q J Med 96:809–824.
  • C Bismuth, R Garnier, S Dally, PE Fournier, and JM Schermann. (1982). Prognosis and treatment of paraquat poisoning: a review of 28 cases. J Toxicol Clin Toxicol 19:461–474.
  • JA Vale, TH Meredith, and BM Buckley. (1987). Paraquat poisoning: clinical features and immediate general management. Hum Toxicol 6:41–47.
  • JL Lin, DT Lin-Tan, KH Chen, and WH Huang. (2006). Repeated pulse of methylprednisolone and cyclophosphamide with continuous dexamethasone therapy for patients with severe paraquat poisoning. Crit Care Med 34 (2):368–373.
  • TJ Gross, and GW Hunninghake. (2001). Idiopathic pulmonary fibrosis. N Engl J Med 345:517–525.
  • RV Nair, X Huang, R Shorthouse, and et al. (1997). Antiproliferative effect of rapamycin on growth factor-stimulated human adult lung fibroblasts in vitro may explain its superior efficacy for prevention and treatment of allograft obliterative airway disease in vitro. Transplant Proc 29:614–615.
  • L Buschhausen, M Kamm, W Arns, and et al. (Mar 15, 2005). Successful treatment of a severe case of idiopathic pulmonary fibrosis with rapamycin. Med Klin 100 (3):161–4. (Munich)
  • SN Sehgal. (1998). Rapamune (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression. Clin Biochem 31:335–340.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.